Please login to the form below

Not currently logged in
Email:
Password:

pulmonary fibrosis

This page shows the latest pulmonary fibrosis news and features for those working in and with pharma, biotech and healthcare.

Ocrevus helps Roche shrug off biosimilars in 2018

Ocrevus helps Roche shrug off biosimilars in 2018

New haemophilia drug Hemlibra (emicizumab) added 224m francs, which Schwan said was ahead of expectations – and Esbriet (pirfenidone) for lung disease idiopathic pulmonary fibrosis (IPF) brought in just over 1bn francs,

Latest news

More from news
Approximately 7 fully matching, plus 42 partially matching documents found.

Latest Intelligence

  • Deal Watch October 2018

    Ark has in-licensed the global rights to the phase 1. idiopathic pulmonary fibrosis programme. ... the phase 1 product AK3280 (GDC3280) for the treatment of idiopathic pulmonary fibrosis.

  • 30 Women Leaders in UK Healthcare (part 3) 30 Women Leaders in UK Healthcare (part 3)

    2004. Fifteen years on, the company’s lead product candidate, Lynovex, for the treatment of acute pulmonary exacerbations in Cystic Fibrosis, was recently granted FDA Fast Track Designation.

  • Getting multichannel marketing right Getting multichannel marketing right

    In recent years, Merck has run an animated video to raise awareness of thyroid disorders, Roche has recorded a choir made up of families affected by idiopathic pulmonary fibrosis and AstraZeneca

  • Significant figures Significant figures

    NTM is a rare progressive, destructive infection that’s normally found in addition to pulmonary diseases such as chronic obstructive pulmonary disease (COPD), cystic fibrosis or bronchiectasis. ... Its novel therapy is an inhaled formulation of

  • Deal Watch June 2016 Deal Watch June 2016

    pulmonary fibrosis (IPF) with cough. ... licence, collaboration. 2, 560. Afferent Pharmaceuticals/ Merck &Co. AF-219, oral P2X3 antagonist for chronic cough (p2b) and idiopathic pulmonary fibrosis (p2) with cough, and other compounds.

More from intelligence
Approximately 0 fully matching, plus 11 partially matching documents found.

Latest appointments

More from appointments
Approximately 0 fully matching, plus 2 partially matching documents found.

Latest from PMHub

  • Innovation and technology at Roche’s “Air Spain” Event

    The event Air Spain organised by Roche, spoke about how to  optimise research, knowledge and treatment of idiopathic pulmonary fibrosis.

  • Understanding the "Big Picture"

    For example, a technology originally intended to monitor the presence of lung fibrosis in idiopathic pulmonary fibrosis (IPF) but then finding utility in other fibrotic lung diseases. ... Keeping with the example of fibrosis, if the targets are viable,

More from PMHub
Approximately 1 fully matching, plus 1 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Ashfield

Ashfield, part of UDG Healthcare plc, is a global leader in commercialisation services for the healthcare industry. We partner with...

Latest intelligence

50 questions for delivering an exceptional healthcare brand experience
Our 50-question brand planning checklist for healthcare ensures you deliver an exceptional experience, based on what your stakeholders want and need...
The brand strategy revolution
Introducing a new tool for developing a stakeholder-centric brand, based on the experience your patients and their HCPs want and need....
How Medisafe is using AI to improve patient adherence
Dina Patel speaks to Omri Shor, Co-Founder and CEO of Medisafe, to find out how his medication management app is tackling the problem of poor adherence....

Infographics